How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

541 results for

Postpartum Endometritis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

241. Continued Versus Discontinued Oxytocin Stimulation of Labour

Oxytocin Stimulation of Labour (CONDISOX) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02553226 Recruitment Status : Recruiting First Posted : September 17, 2015 Last Update Posted : July 2, 2018 See Sponsor: University (...) changed for a blinded infusion-set. Other Name: Isotonic saline Outcome Measures Go to Primary Outcome Measures : Caesarean section [ Time Frame: labour ] Frequency of acute performed caesarean sections Secondary Outcome Measures : Instrumental delivery [ Time Frame: 0-48 hours ] use of vacuum extraction or forceps for delivery Birth experience [ Time Frame: 4 weeks postpartum ] Childbirth Experience Questionaire (CEQ) Breastfeeding [ Time Frame: 0-6months ] Time to established feeding and duration

2015 Clinical Trials

242. Effect of a Patient-Centered Decision App on TOLAC

, postpartum febrile morbidity (endometritis, cellulitis, urinary tract infection, or other infection), as noted in the medical record for her delivery. 3rd or 4th Degree Lacerations [ Time Frame: Collected 0 to 8 weeks after delivery. ] 3rd or 4th degree lacerations, as noted in the medical record for her delivery. Neonatal Death or HIE [ Time Frame: Collected 0 to 8 weeks after delivery. ] Stillbirth/fetal demise (antepartum or intrapartum), neonatal death, HIE, as noted in the medical record for her (...) (PROCEED) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02646423 Recruitment Status : Recruiting First Posted : January 5, 2016 Last Update Posted : September 13, 2018 See Sponsor: University of California, San Francisco

2015 Clinical Trials

243. Comparison of Uterine Repair Methods for Cesarean Delivery

for Cesarean Delivery The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02587013 Recruitment Status : Completed First Posted : October 27, 2015 Last Update Posted : December 17, 2018 Sponsor: Maisonneuve-Rosemont Hospital Information provided by (Responsible Party): Valerie Zaphiratos, Maisonneuve-Rosemont (...) % of the baseline mean arterial pressure, despite a phenylephrine infusion Pelvic irrigation [ Time Frame: Intraoperative ] To determine if the patient had pelvic irrigation, yes or no Length of surgery [ Time Frame: Intraoperative ] Estimated blood loss [ Time Frame: Intraoperative ] Measuring suction canisters and wet sponges Reduction in hemoglobin [ Time Frame: Within 24 hours of surgery ] Difference between preoperative and postoperative hemoglobin within 24 hours of surgery Incidence of endometritis

2015 Clinical Trials

244. Preterm Premature Rupture of Membranes, Outpatient Management vs Inpatient Management

First Posted : September 14, 2015 Last Update Posted : September 14, 2015 Sponsor: Ain Shams Maternity Hospital Collaborator: Ain Shams University Information provided by (Responsible Party): dina mostafa ibrahim, Ain Shams Maternity Hospital Study Details Study Description Go to Brief Summary: This study is to compare the maternal and neonatal outcomes in the patients with PPROM who are managed at home versus those managed at hospital, half the patients will be managed at home and the other half (...) management patients will continue there treatment in hospital till delivery Outcome Measures Go to Primary Outcome Measures : rate occurence of Neonatal sepsis [ Time Frame: 48 hours after delivery ] proven neonatal infection with positive blood culture within 48 hours after birth, or culture proven neonatal pneumonia or meningitis Secondary Outcome Measures : rate of occurence of Maternal morbidity [ Time Frame: 48 hours after delivery ] including chorioamnionitis , endometritis , septicaemia, admission

2015 Clinical Trials

245. Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation

, endometritis or postpartum hemorrhage Administration of greater than 5 mg of amlodipine in 24 hour period Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02353806 Locations Layout table for location information United States, Texas Parkland Health (...) . Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02353806 Recruitment Status : Completed First Posted : February 3, 2015 Results First Posted : February 6, 2019 Last Update Posted : February 6, 2019 Sponsor: University of Texas Southwestern

2015 Clinical Trials

246. Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

medications other than AEDs (griseofulvin, rifampin, St. John's Wort, bosentan) Depomedroxyprogesterone acetate within previous six months Congenital or acquired uterine anomaly, including myomas, that distort the uterine cavity Acute pelvic infection or a history pelvic infection without subsequent intrauterine pregnancy Postpartum endometritis or infected abortion in the last three months Genital bleeding of unknown etiology Untreated lower genital tract infection (cervical or vaginal) Acute liver (...) First Posted : February 12, 2015 Results First Posted : January 18, 2016 Last Update Posted : January 18, 2016 Sponsor: Columbia University Collaborator: Bayer Information provided by (Responsible Party): Anne Davis, Columbia University Study Details Study Description Go to Brief Summary: The investigators will conduct a prospective, seven-month pilot study to explore pharmacokinetic (PK) and pharmacodynamic (PD) effects among women with epilepsy using the levonorgestrel intrauterine system (LNG IUS

2015 Clinical Trials

247. Quality of intrapartum care by skilled birth attendants in a refugee clinic on the Thai-Myanmar border: a survey using WHO Safe Motherhood Needs Assessment. Full Text available with Trip Pro

practice included: presence of a support person; active management of third stage; post-partum monitoring; and immediate and correct neonatal care. Observed incorrect practice included: improper controlled cord traction; inadequate hand washing; an episiotomy rate in nulliparous women 49% (34/70) and low rates 30% (6/20) of newborn monitoring in the first hours following birth. Overall observed complications during labour and birth were low with post-partum haemorrhage being the most common in which (...) . a stand-by emergency car, was present. Syphilis testing was not available. SBA interviews established that danger signs and symptoms were recognized except for sepsis and endometritis. All SBAs acknowledged receiving theoretical and 'hands-on' training and regularly attended deliveries. Scores for the essential elements of antenatal care from maternal records were high (>90%) e.g. providing supplements, recording risk factors as well as regular and correct partogram use. Observed good clinical

2015 BMC Pregnancy and Childbirth

248. 17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial. (Abstract)

suggested that continuation was futile. The primary outcome was achieved in 3% of the 17OHP-C group and 8% of the placebo group (P = .18). There was no significant between-group difference in the prespecified secondary outcomes, randomization-to-delivery interval (17.1 ± 16.1 vs 17.0 ± 15.8 days, respectively; P = .76) or composite adverse perinatal outcome (63% vs 61%, respectively; P = .93). No significant differences were found in other outcomes, which included rates of chorioamnionitis, postpartum (...) endometritis, cesarean delivery, individual components of the composite outcome, or prolonged neonatal length of stay.Compared with placebo, weekly 17OHP-C injections did not prolong pregnancy or reduce perinatal morbidity in patients with PROM in this trial.Copyright © 2015 Elsevier Inc. All rights reserved.

2015 American Journal of Obstetrics and Gynecology Controlled trial quality: predicted high

249. Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor

year ] vaginal delivery [ Time Frame: up to one and a half year ] Postpartum hemorrhage [ Time Frame: up to one and a half year ] Maternal intrapartum chorioamnionitis [ Time Frame: up to one and a half year ] Maternal postpartum endometritis [ Time Frame: up to one and a half year ] Neonatal respiratory distress [ Time Frame: up to one and half year ] Other Outcome Measures: Neonatal intraventricular hemorrhage [ Time Frame: up to one and half year ] Neonatal pneumonia [ Time Frame: up to one (...) adding more. Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02511444 Recruitment Status : Active, not recruiting First Posted : July 30, 2015 Last Update Posted : August 21, 2018 Sponsor: MemorialCare Health System

2015 Clinical Trials

250. Prophylactic antibiotics effective for women undergoing caesarean section

of endometritis following both elective and nonelective caesarean section by two-thirds to three-quarters and the incidence of wound infection by up to three-quarters. Postpartum febrile morbidity and the incidence of urinary tract infections were also decreased. Fewer serious complications were identified. The administration of prophylactic antibiotics before or after clamping of the cord seemed equally effective for women undergoing caesarean section. The antimicrobial agents most often used in the trials

2011 Cochrane PEARLS

251. [Influence of feeding rumen-protected choline to transition dairy cows. Part 2: Health and reproduction]. (Abstract)

days post partum (p. p.) as a top dressing. Health data was analyzed for the incidence of fever within the first 10 days in milk (DIM) as well as the incidence of diseases and the culling rate within the first 200 DIM. Reproduction data were evaluated in terms of the calving data, uterine involution on days 10, 21 and 42 p. p., uterine cytology at day 42 p. p., progesterone concentrations during weeks 3 and 5 p. p. and certain fertility measures. In the statistical analysis, it was differentiated (...) between the control and treatment groups and between primi- and multiparous animals, and their interactions were analyzed.The treatment group had less cows with subclinical endometritis, higher sickness rates after day 100 p. p., lower numbers of stillbirths and more cyclic cows in week 5 p. p. compared to the control group (p  <  0.05). Primipara in contrast to multipara had fever more frequently, higher rates of subclinical ketosis p. p., metritis and lameness, higher numbers of sick cows

2014 Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere Controlled trial quality: uncertain

252. Denaverine hydrochloride and carbetocin increased welfare during and after parturition and enhanced subsequent fertility in cattle. Full Text available with Trip Pro

Denaverine hydrochloride and carbetocin increased welfare during and after parturition and enhanced subsequent fertility in cattle. The objectives of the current study were to investigate the influence of denaverine hydrochloride and carbetocin on softening and dilatation of the birth canal, the need for assistance during parturition, calf mortality, retention of fetal membranes, endometritis, and subsequent fertility. Altogether 200 animals (100 cows and 100 heifers) of the Simmental breed (...) were divided into 2 groups: treatment (n = 100) and control (n = 100). Animals in the treatment group received denaverine hydrochloride and carbetocin (a maximum of twice for each, depending on the progression of labor) during delivery over a maximum of 4 waiting periods (30 min each), whereas control animals experienced the same waiting periods but received no treatment. The treatment protocol had a positive influence on the ease of calving and postpartum reproductive health. The treatment

2014 Journal of dairy science Controlled trial quality: uncertain

253. A Multi-Center, Single Arm Clinical Study of the Safety and Efficacy of the AURORAâ„¢ Endometrial Ablation System

) which the patient is unwilling to have removed at the time of the operative visit Presence of an implantable contraceptive device (e.g. Essure or Adiana). Subject currently on hormonal birth control therapy or unwilling to use a non-hormonal birth control post-ablation (including a Mirena device). Subject who is within 6-weeks post partum. Any general health condition which, in the opinion of the Investigator, could represent an increased risk for the subject Any subject who is currently (...) studies (100). Please remove one or more studies before adding more. A Multi-Center, Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02029911 Recruitment Status : Completed First Posted : January 8, 2014

2014 Clinical Trials

254. Cervical Ripening in Premature Rupture of Membranes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02314728 Recruitment Status : Unknown Verified March 2016 by Montefiore Medical Center. Recruitment status was: Recruiting First Posted : December 11, 2014 Last Update Posted : March 17, 2016 Sponsor: Montefiore Medical Center Information provided (...) the most significant maternal and neonatal sequelae associated with PROM and this risk increases with the length of time from ruptured membrane to delivery. Induction of labor has been shown to reduce the rates of chorioamnionitis, endometritis and NICU admissions4. Specifically, induction of labor with prostaglandin agents followed by oxytocin, versus oxytocin alone has been shown to be effective for labor induction resulting in vaginal delivery. Management strategies for PROM have been controversial

2014 Clinical Trials

255. Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by "Point-of-care" During Pregnancy

of endometritis [ Time Frame: 30 months ] the preterm birth rate adjusted [ Time Frame: 30 months ] he total duration of hospitalization and earlier for postpartum mother and newborn in number of days [ Time Frame: 30 months ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may (...) Identifier: NCT02288832 Recruitment Status : Completed First Posted : November 11, 2014 Last Update Posted : September 3, 2018 Sponsor: Assistance Publique Hopitaux De Marseille Information provided by (Responsible Party): Assistance Publique Hopitaux De Marseille Study Details Study Description Go to Brief Summary: Infection is the principal cause of preterm births. Most (90%) women with preterm deliveries have no abnormal history. It is widely agreed that preterm delivery is often associated

2014 Clinical Trials

256. Safety Study of Hyoscine N Butyl Bromide in Active Management of Labor

outcomes [ Time Frame: up to 7 month ] Maternal complications of drug-related side effects (nausea, vomiting, pruritus, rash, mouth establishment, collided), postpartum hemorrhage (more than 500cc), 3th or 4th degree vaginal tears, intrapartum chorioamnionitis (38 ° C higher fever, vaginal temperature increase, uterine tenderness, or Fetal heart rate above 160 to be), postpartum endometritis (first 24 hours, 38 ° C higher with fever uterine tenderness, purulent foul-smelling discharge) covers. Safety (...) of Hyoscine N Butyl Bromide in Active Management of Labor (HBB) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02098889 Recruitment Status : Completed First Posted : March 28, 2014 Last Update Posted : March 28, 2014 Sponsor: Sisli Hamidiye Etfal Training and Research Hospital Information provided

2014 Clinical Trials

257. Randomized Control Trial of Second Stage of Labor

Outcome Measures: Operative Vaginal Delivery [ Time Frame: at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual" ] Spontaneous Vaginal Delivery [ Time Frame: at time of delivery, 4 hours second stage for "Extended" 3 hours second stage for "Usual" ] Endometritis [ Time Frame: at time of delivery until maternal discharge, usually < 5 days ] Clinical diagnosis of postpartum endometritis of the mother Transfusion [ Time Frame: at time of delivery until maternal (...) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02101515 Recruitment Status : Completed First Posted : April 2, 2014 Results First Posted : October 26, 2018 Last Update Posted : October 26, 2018 Sponsor: Thomas Jefferson University Information provided by (Responsible Party): alexis gimovsky, Thomas

2014 Clinical Trials

258. Extra-abdominal Removal of Placenta During CS

and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02101450 Recruitment Status : Completed First Posted : April 2, 2014 Last Update Posted : January 13, 2015 Sponsor: Near East University, Turkey Information provided by (Responsible Party): Baris KAYA, Near East University, Turkey Study Details Study Description Go (...) of the placenta) may decrease the amount of blood flowing into the abdominal cavity during removal of placenta. In this study the investigators aimed to evaluate the influence of intra abdominal vs extra abdominal removal of placenta on duration of operation, the amount of aspirated fluid during the operation, difference between postoperative hemoglobin and hematocrit levels, postoperative pain score, additional need of analgesia, postoperative bowel movements, postoperative endometritis and wound infection

2014 Clinical Trials

259. Antibiotics and Gut Microbiota Among Newborn Infants

University of Southern Denmark Information provided by (Responsible Party): Nana Hyldig, Odense University Hospital Study Details Study Description Go to Brief Summary: Background Women undergoing Caesarean Section (CS) have an increased risk of postpartum infections compared to women undergoing vaginal delivery. In Denmark the incidence of post-CS infections is 7-10%. The most common infections are endometritis, Urinary tract infections (UTI) and wound infections (WI). Prophylactic antibiotics (...) , especially for the weakest newborn infants. This pilot study will be a feasibility study to the original study, which examines the effect of change in timing of prophylactic antibiotics on the rate of post-CS infections (endometritis, UTI and WI). The pilot study focus on antibiotic and changes in the gut microbiota of newborn infants. The feasibility study will only include pregnant women in Odense with a body mass index below 30, and planned cesarean section. Condition or disease Intervention/treatment

2014 Clinical Trials

260. Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness

or vaginal injections/lesions or complaints, as well as undiagnosed abnormal genital bleeding History of chronic pelvic pain, interstitial cystitis, vulvar vestibulitis, pelvic inflammatory disease within the past 12 weeks Known current clinically evident cervical or vaginal infection Postpartum or post-abortion endometritis, unless symptoms resolved at least 12 weeks prior to study entry Current persistent, abnormal vaginal bleeding History of inability to place an IVR History of any abnormality (...) before adding more. Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02029053 Recruitment Status : Completed First Posted : January 7, 2014 Last Update Posted : December 15, 2015 Sponsor: J3 Bioscience, Inc

2014 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>